Home Cart Sign in  
Chemical Structure| 76996-27-5 Chemical Structure| 76996-27-5

Structure of Garcinone C
CAS No.: 76996-27-5

Chemical Structure| 76996-27-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Garcinone C, a natural product isolated and purified from the fruits of Garcinia mangostana, is the most potent inhibitor of AChE, the most active compound against both of pathogenic (MIC =100 μg/mL) and non-pathogenic leptospira (MIC = 200 μg/mL), and exhibits either significant or moderate cytotoxicity against MCF-7, A549, Hep-G2 and CNEhuman cancer cell lines in vitro.

Synonyms: Garcinone C

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Garcinone C

CAS No. :76996-27-5
Formula : C23H26O7
M.W : 414.45
SMILES Code : O=C1C2=C(OC3=C1C(CCC(C)(O)C)=C(O)C(O)=C3)C=C(O)C(C/C=C(C)\C)=C2O
Synonyms :
Garcinone C
MDL No. :MFCD11111285

Safety of Garcinone C

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDA-MB-231 5 μM 24 hours Restored TBK1 phosphorylation in PD-L1 KO cells EMBO Rep. 2025 Feb;26(3):635-655
BMDM cells 0, 0.2, 1, 5 μmol/L 5 days To investigate the inhibitory effect of Garcinone C on RANKL-induced osteoclast differentiation. Results showed that Garcinone C significantly inhibited osteoclast differentiation and bone resorption function. Heliyon. 2024 Feb 1;10(3):e25601
RAW264.7 cells 0, 0.2, 1, 5 μmol/L 5 days To investigate the inhibitory effect of Garcinone C on RANKL-induced osteoclast differentiation. Results showed that Garcinone C dose-dependently reduced the osteoclast area and significantly inhibited the formation of multinucleated osteoclasts. Heliyon. 2024 Feb 1;10(3):e25601
MDA-MB-231 5 μM 5 days Restored IL-6 and GM-CSF expression in PD-L1 KO cells EMBO Rep. 2025 Feb;26(3):635-655
MDA-MB-231 5 μM 5 days Restored cGAMP production in PD-L1 KO cells EMBO Rep. 2025 Feb;26(3):635-655
22Rv1 cells IC50 value of 22.62 μM 48 hours Evaluated the cytotoxicity of Garcinone C on prostate cancer cells 22Rv1, showing an IC50 value of 22.62 μM. Nat Prod Res. 2021 Dec;35(23):5429-5433
MDA-MB-231 cells IC50 value of 22.62 μM 48 hours Evaluated the cytotoxicity of Garcinone C on breast cancer cells MDA-MB-231, showing an IC50 value of 22.62 μM. Nat Prod Res. 2021 Dec;35(23):5429-5433
HepG2 cells 6, 8, 10 μg/mL 48 hours To evaluate the inhibitory effect of Garcinone C on the growth of HepG2 cells, results showed IC50 of 6.23 μg/mL (extract) and 5.78 μg/mL (nanoemulsion). Int J Mol Sci. 2023 Feb 15;24(4):3934

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice OVX-induced osteoporosis model Intraperitoneal injection 5 mg/kg and 25 mg/kg Every 2 days for 8 weeks To investigate the therapeutic effect of Garcinone C on OVX-induced osteoporosis. Results showed that Garcinone C significantly increased bone mineral density, reduced bone loss, and inhibited the expression of osteoclast-related proteins. Heliyon. 2024 Feb 1;10(3):e25601

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.41mL

0.48mL

0.24mL

12.06mL

2.41mL

1.21mL

24.13mL

4.83mL

2.41mL

References

 

Historical Records

Categories